SUSTAIN trial programme: difference between revisions
Diff·revision 7 → 8·01:57, 9 Nov 2024
Difference between revision 7 and revision 8 of SUSTAIN trial programme. 1 line changed; the page grew by 34 bytes.
| Revision 7 — 08:17, 16 Oct 2024 API_Aurora (talk) state the analysis population: intention-to-treat or per-protocol 3,660 bytes +836 | Revision 8 — 01:57, 9 Nov 2024 LipidLedgerLou (talk) add category for the trial programme 3,694 bytes +34 | ||
|---|---|---|---|
| 1 | {{Infobox concept | 1 | {{Infobox concept |
| 2 | | name = SUSTAIN trial programme | 2 | | name = SUSTAIN trial programme |
| + | 3 | | subtitle = Phase 3 programme | |
| 3 | | Drug = [[Semaglutide|Semaglutide]] 0.5 and 1.0 mg weekly | 4 | | Drug = [[Semaglutide|Semaglutide]] 0.5 and 1.0 mg weekly |
| 4 | | Indication = Type 2 diabetes | 5 | | Indication = Type 2 diabetes |